oxi internasional

They focus on naturally occurring protective substances since it is more likely safe for us. The primary products incorporate and emphasize the multifaceted “super antioxidant” compound, L- Ergothioneine (“ERGO”), as a key component. Oxis own several patents and pending applications related to ERGO that cover current and planned products relevant to our nutraceutical and cosmecuetical businesses. The patents and patent applications address ERGO’s protective effects and activities and the ERGO manufacturing process. They also offer some product that rich in Glutahione, and there are still some people who know that their product is penny stocks and free radical. Oxis is the starting position for the proper product into the health market with plenty of room for expansion
See Oxis webpage
See Oxis on Twitter
See Oxis on Facebook

Oxis International, Inc. (OXIS) is principally engaged in the research and development of technologies and therapeutic products in the field of oxidative stress/inflammatory reaction. The company’s main divisions are Oxissearch, Ergothioneine and Therapeutics. It owns Biocheck, a provider of enzyme immunoassay research services and products which focuses on the immunoassay segment of the clinical diagnostics market. OXIS is headquartered in California, U.S.